• BX Home
  • Business of Biotechnology: Blog [Page 10]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,259 news and 4,837 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 24 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Symonds Steps Down as Novartis CFO, Kirsch Takes Overmore

Welcome to this week's roundup of hirings and firings throughout the industry. Please send the good word (or the bad)...

Theravance to split into two companiesmore

Theravance ($THRX) plans to break apart into two publicly traded companies. The South San Francisco-based biotech...

Bristol-Myers gains FDA's 'breakthrough' track in race for hep C drug ...more

Bristol-Myers Squibb ($BMY) just gained an inside regulatory track in the frantic race to get new interferon-free...

Radius nabs $43M round for PhIII bone-building drugmore

Radius Health joined the lineup of biotechs announcing big new venture rounds today. The Cambridge, MA-based developer,...

Experienced biotech team snags $33M for promising PhII cholesterol dru...more

Now that the successful biopharma team of Roger Newton and Tim Mayleben has reunited to run an upstart--Esperion--with...

Acumen Pharma reveals A round closing to fund Alzheimer's drug researc...more

Driven to test another amyloid-beta mechanism in Alzheimer's, Acumen Pharmaceuticals has wrapped up the first closing...

Where are India’s Drug Patents?more

Copyright © thinkBiotech As I continue to investigate global biotechnology for Scientific American and international...

Drug Patent Expirations for Apr 3 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 14 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 16 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Apr 24 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

French biotech Genticel lands $23.7M for 'blockbuster' HPV vaccine hop...more

Some top life sciences investors have backed France-based vaccine developer Genticel in an €18.2 million round of...

Drug Patent Expirations by Yearmore

Copyright © thinkBiotech This live infographic dynamically shows the number of pending patent expirations by year for...

OPKO Health to acquire Prolor Biotech for $480Mmore

OPKO Health ($OPK) announced today that it is poised to acquire Israel-based Prolor Biotech in an all-stock transaction...

AstraZeneca, Aussie biotech outfit ally in $240M-plus discovery dealmore

AstraZeneca's partnership spree of the last two months has gone Down Under. As the company shrinks its internal...

Scientific American Worldview Issue 5 at #BIO2013more

Copyright © thinkBiotech I continue to measure global biotechnology innovation in the fifth  edition of Scientific...

BIO: R&D execs say tweaks boost drug-development processmore

Panel from left to right: Jose-Carlos Gutiérrez-Ramos, Pfizer; Briggs Morrison, AstraZeneca; John Carroll,...

Chicago uses its turn in BIO spotlight to promote incubator plansmore

The city of Chicago is hoping to take advantage of the spotlight of the annual BIO convention to build up its biotech...

Which pharmaceutical companies face the most patent expirations this y...more

Copyright © thinkBiotech This infographic from DrugPatentWatch shows that Sanofi Aventis...

Moody's: Deep-pocketed pharma giants poised to boost M&A activity ...more

Here's a multibillion-dollar question: With their improved cash positions, will pharma companies increase spending this...

Gilead keeps lead in hep C race after rivals post key trial resultsmore

After delivering data from multiple rounds of trials on all-oral combos against hepatitis C, pharma runners appear to...

Book signings at #bio2013more

Copyright © thinkBiotech Join Michael Salgaller and I as we will be signing our books at the BIO bookstore on Tuesday...

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: Jun 14
SOFTWARE ENGINEER at exciting biotech company! Adaptive Biotechnologies | Seattle, WA
Posted: Apr 19
Biotech Oncology Marketing Companion Diagnostics Alpine Group | Washington, DC
Posted: Jun 17
Equity Research Analyst-Biotechnology-NY, CHI or MKE Robert W. Baird | New York, NY
Posted: Apr 22

Report comment contains invalid characters. ()
cancel
Search Cancel